Suppliers / Sichuan Long March Pharmaceutical

Sichuan Long March Pharmaceutical

China Updated 9 July 2026

Sichuan Long March Pharmaceutical is an API manufacturer based in China. It holds 2 active US drug master files and 2 valid CEPs across a filed portfolio of 5 molecules.

2
active US DMFs
2
valid CEPs
1
registered plants
0
filings across 0 regulators

Registered plants

Site FDA FEI
Leshan, China Not on file

What they file, and where

Molecule Regulators Docs
Dihydrostreptomycin Sulfate For Veterinary Use EDQM 1
Framycetin SFDA (Saudi Arabia) 1
Neomycin EDQM 1
Oxytetracycline US FDA 1
Streptomycin US FDA 1

Also appears on these molecule pages

Comparing suppliers?

Choose your molecules and target markets. Sichuan Long March Pharmaceutical comes back tiered against every other supplier able to file there.

Start for free
No sales call.

Sources on this page

FDA
Drug master files, establishment registration, inspection classifications
EDQM
Certificates of suitability